| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T204 |
2-10 |
NN |
denotes |
cytokine |
| T205 |
11-13 |
IN |
denotes |
in |
| T206 |
14-22 |
NN |
denotes |
COVID-19 |
| T207 |
23-33 |
VBD |
denotes |
correlated |
| T208 |
34-38 |
IN |
denotes |
with |
| T209 |
39-47 |
NN |
denotes |
severity |
| T210 |
47-48 |
-COMMA- |
denotes |
, |
| T211 |
49-60 |
NN |
denotes |
criticality |
| T212 |
60-61 |
-COMMA- |
denotes |
, |
| T213 |
62-67 |
JJ |
denotes |
viral |
| T214 |
68-72 |
NN |
denotes |
load |
| T215 |
72-73 |
-COMMA- |
denotes |
, |
| T216 |
74-77 |
CC |
denotes |
and |
| T217 |
78-87 |
NN |
denotes |
prognosis |
| T218 |
88-90 |
IN |
denotes |
of |
| T219 |
91-99 |
NNS |
denotes |
patients |
| T220 |
100-104 |
IN |
denotes |
with |
| T221 |
105-113 |
NN |
denotes |
COVID-19 |
| T222 |
115-126 |
NNP |
denotes |
Tocilizumab |
| T223 |
126-127 |
-COMMA- |
denotes |
, |
| T224 |
128-129 |
DT |
denotes |
a |
| R196 |
T204 |
T205 |
arg1Of |
cytokine,in |
| R197 |
T216 |
T205 |
arg2Of |
and,in |
| R198 |
T206 |
T207 |
arg2Of |
COVID-19,correlated |
| R199 |
T207 |
T208 |
arg1Of |
correlated,with |
| R200 |
T209 |
T208 |
arg2Of |
severity,with |
| R201 |
T209 |
T210 |
arg1Of |
severity,"," |
| R202 |
T211 |
T210 |
arg2Of |
criticality,"," |
| R203 |
T206 |
T212 |
arg1Of |
COVID-19,"," |
| R204 |
T214 |
T212 |
arg2Of |
load,"," |
| R205 |
T214 |
T213 |
arg1Of |
load,viral |
| R206 |
T216 |
T215 |
arg1Of |
and,"," |
| R207 |
T212 |
T216 |
arg1Of |
",",and |
| R208 |
T217 |
T216 |
arg2Of |
prognosis,and |
| R209 |
T217 |
T218 |
arg1Of |
prognosis,of |
| R210 |
T219 |
T218 |
arg2Of |
patients,of |
| R211 |
T219 |
T220 |
arg1Of |
patients,with |
| R212 |
T221 |
T220 |
arg2Of |
COVID-19,with |
| R213 |
T222 |
T223 |
arg1Of |
Tocilizumab,"," |